Tricor Related Clinical Trials
A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia [Active, not recruiting]
Evaluation of Efficacy and Safety of Omacor (Omega-3-Acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by 2 Extensions [Completed]
The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study [Active, not recruiting]
Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL) Physicochemical and Functional Characteristics in Patients With Coronary Heart Disease [Recruiting]
Predictors of Response to Fenofibrate [Recruiting]
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza� in Patients With Severe Hypertriglyceridemia [Recruiting]
A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic [Recruiting]
The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans [Recruiting]
Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin [Active, not recruiting]
Zolip 0501: Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy [Active, not recruiting]
A Trial in Adults With Type 1 Diabetes Mellitus Evaluating the Effects of Fenofibrate Versus Placebo on Macular Thickness and Volume [Not yet recruiting]
Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia [Recruiting]
Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients [Recruiting]
Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation [Recruiting]
Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate [Recruiting]
Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate [Recruiting]
Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin [Recruiting]
Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia [Recruiting]
Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate [Recruiting]
Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome [Recruiting]
Effect of SAR236553 (REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects [Recruiting]
A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome [Available]
Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients [Recruiting]
Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL) [Recruiting]
Lipid Biomarkers for Diabetic Heart Disease [Not yet recruiting]
Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids [Completed]
Fenofibrate and Pharmacogenetic Impact in Dyslipidemia [Recruiting]
Use of Fenofibrate for Primary Biliary Cirrhosis [Recruiting]
Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis [Not yet recruiting]
Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin [Active, not recruiting]
Zolip 0502: Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy [Active, not recruiting]
Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study [Terminated]
The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART) [Completed]
Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-Lowering Strategy [Completed]
Effect of Fenofibrate on Kidney Function: a Six-Week Randomized Cross-Over Trial in Healthy People [Completed]
A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin [Completed]
Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study [Active, not recruiting]
Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides. [Recruiting]
Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis [Completed]
Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome [Completed]
A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients. [Completed]
Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia [Completed]
Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate [Completed]
Pharmacological Regulation of Fat Transport in Metabolic Syndrome [Completed]
A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome [Completed]
GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate [Terminated]
Pilot Study of Fenofibrate in Primary Sclerosing Cholangitis [Recruiting]
Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia [Completed]
Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI [Terminated]
Study of Trilipix Effects on Lipids and Arteries [Recruiting]
Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia [Recruiting]
AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis [Recruiting]
The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers [Recruiting]
Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Treating Young Patients With Relapsed or Progressive Cancer [Recruiting]
LXRA Gene Polymorphisms and Response to Fenofibrate [Recruiting]
Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033 [Withdrawn]
Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes [Completed]
Acceptability of a Fixed Combination of Fenofibrate and Metformin [Completed]
Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO [Active, not recruiting]
Effect of a Fibrate and a Statin on Endothelial Dysfunction [Recruiting]
High-Density Lipoprotein (HDL) Cholesterol in Women Taking Tibolone [Recruiting]
Effect of Choline Fenofibrate (SLV348) on Macular Edema [Recruiting]
Assessment of Mechanisms of Improved Wound Healing [Recruiting]
Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia [Available]
Effect of a PPAR-Alpha Agonist on the Age Related Changes in Myocardial Metabolism and Mechanical Function [Recruiting]
Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia [Completed]
Insulin Resistance in Non-alcoholic Fatty Liver Disease [Recruiting]
High-Density Lipoprotein (HDL) Treatment Study [Completed]
Substrate Cycling in Energy Metabolism [Completed]
Dyslipidemia Study Investigating The Increase In "Good Cholesterol" [Completed]
Two Investigational Drugs in Patients With Mixed Hyperlipidemia [Completed]
The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines [Not yet recruiting]
Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS [Active, not recruiting]
Obesity and Nonalcoholic Fatty Liver Disease [Recruiting]
Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia [Completed]
Anti-Angiogenic Chemotherapy:Oral 5-Drug Regimen in Patients With Relapsed or Progressive Cancer [Recruiting]
Insulin Resistance in Non-alcoholic Fatty Liver Disease [Recruiting]
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder. [Terminated]
Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-Lowering Agents [Completed]
12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia [Active, not recruiting]
Tissue Lipids and Insulin Resistance [Not yet recruiting]
Effectiveness of Two Approved Drugs in Lowering High Cholesterol
Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia [Not yet recruiting]
Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules [Not yet recruiting]
A Study in People With Abnormal Fat Levels in the Blood
A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia
Combined Effects of Non-Statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study [Recruiting]
Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma [Recruiting]
Genetic and Environmental Determinants of Triglycerides (GOLDN) [Active, not recruiting]
Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides [Not yet recruiting]
Assessment of the Effect of Food on ABT-143 Bioavailability [Recruiting]
|
